Press Release Jun 19 2023
Filed with NSE · · 3 pages · English
Summary by 6ix AI
Laurus Labs Ltd. has signed a Memorandum of Agreement with IIT Kanpur to develop novel gene therapy assets. The agreement includes in-licensing gene therapy assets and funding for pre-clinical and clinical trials. Laurus Labs will also establish a GMP facility at IIT Kanpur's Techno Park. This partnership aims to enhance access to gene therapies in India and emerging markets. The CEO expressed excitement about the collaboration's potential to provide affordable treatments.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Earlier from Laurus Labs
- Press Release May 31 2023
- Press Release May 02 2023
- Press Release Apr 27 2023
- Press Release Jan 30 2023
- Press Release Oct 21 2022
Later from Laurus Labs
- Press Release Jul 27 2023
- Press Release Oct 20 2023
- Press Release Jan 24 2024
- Press Release Jan 25 2024
- Press Release Apr 25 2024
Follow Laurus Labs into a list and get an email when it puts out news.
Follow Laurus Labs